IDLProcycling on MSN7h
Arensman climbs to Paris-Nice podium but was concerned for Skjelmose after race-ending crash: "It looked really bad"
Nice, Thymen Arensman now sits in third place in the Race to the Sun. The INEOS Grenadiers rider finished alongside the other ...
Cyclingnews on MSN5h
'Cycling is a relentless sport' – Skjelmose misses Paris-Nice podium challenge with stage 7 crash
Dane was forced to abandon from third place after colliding with road furniture midway through penultimate stage ...
Cyclingnews on MSN2d
Paris-Nice Queen stage 7 shortened to 109km due to 'unfavourable' weather conditions with two climbs removed
The route for the Queen stage 7 of Paris-Nice 2025 has been modified and shortened due to adverse weather conditions in the ...
The Inner Ring1d
Paris-Nice Stage 7 Preview
Beurk! Le Temps: add wind and rain, subtract Tim Merlier and the result is Mads Pedersen. The Dane got his stage win thanks ...
AFP on MSN1d
Paris-Nice contender Skjelmose hospitalised after fall
Denmark's Paris-Nice hope Mattias Skjelmose quit the race in an ambulance after hitting a traffic island at full speed on ...
The Business Journals1mon
Biotech raises Series B to test cancer drug in the clinic
Auron Therapeutics has raised a $27 million Series B financing that it will use to initiate clinical development of its lead experimental drug, AUTX-703, in blood cancers. From the Boston Business ...
The American Conservative9mon
Are Conservatives Merely Leading a ‘Ghost Dance’?
In his book The Total State, Auron MacIntyre gives a brief and effectual summary of this conservative resourcement, set against the backdrop of the events of 2020 and the author’s development ...
Cyclingnews1d
Paris-Nice: Michael Storer surges from breakaway for victory on stage 7
Breaking news live reporting and analysis from all of the major races ...
Aussie Storer wins in the snow in the 'Race to the Sun'
Australian Michael Storer has kept his cool to win a remarkable mountain-top stage in the snow amid cycling's famed ...
The Business Journals1mon
Biotech raises Series B to test cancer drug in the clinic
Kate Yen is the founder and CEO of Auron Therapeutics. From the Boston Business Journal. Auron Therapeutics has raised a $27 million Series B financing that it will use to initiate clinical ...